Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of Fatigue in Head and Neck Cancer Survivors.
Bossi P, Di Pede P, Guglielmo M, Granata R, Alfieri S, Iacovelli NA, Orlandi E, Guzzo M, Bianchi R, Ferella L, Infante G, Miceli R, Licitra L, Ripamonti CI. Bossi P, et al. Among authors: ferella l. Ann Otol Rhinol Laryngol. 2019 May;128(5):413-419. doi: 10.1177/0003489419826138. Epub 2019 Jan 30. Ann Otol Rhinol Laryngol. 2019. PMID: 30700107
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
Orlandi E, Bonomo P, Ferella L, D'Angelo E, Maddalo M, Alterio D, Infante G, Bacigalupo A, Argenone A, Iacovelli NA, Desideri I, Meduri B, Triggiani L, Volpe S, Belgioia L, Dionisi F, Romanello DA, Fallai C, Miceli R. Orlandi E, et al. Among authors: ferella l. Head Neck. 2019 Oct;41(10):3684-3692. doi: 10.1002/hed.25890. Epub 2019 Jul 29. Head Neck. 2019. PMID: 31355972
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S. Deneuve S, et al. Among authors: ferella l. Tumori. 2023 Apr;109(2):173-185. doi: 10.1177/03008916221078061. Epub 2022 May 16. Tumori. 2023. PMID: 35578746
[No title available]
[No authors listed] [No authors listed] PMID: 37785847
Recommendation for the contouring of limbic system in patients receiving radiation treatment: A pictorial review for the everyday practice and education.
Sorce C, Chalaszczyk A, Rossi F, Ferella L, Grimaldi G, Splendiani A, Genovesi D, Marampon F, Orlandi E, Iannalfi A, Masciocchi C, Gravina GL. Sorce C, et al. Among authors: ferella l. Crit Rev Oncol Hematol. 2021 Mar;159:103229. doi: 10.1016/j.critrevonc.2021.103229. Epub 2021 Jan 19. Crit Rev Oncol Hematol. 2021. PMID: 33482343 Review.
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.
Bresolin A, Faiella A, Garibaldi E, Munoz F, Cante D, Vavassori V, Waskiewicz JM, Girelli G, Avuzzi B, Villa E, Magli A, Noris Chiorda B, Gatti M, Ferella L, Maggio A, Landoni V, Aimonetto S, Sini C, Rancati T, Sanguineti G, Valdagni R, Di Muzio N, Fiorino C, Cozzarini C. Bresolin A, et al. Among authors: ferella l. Radiother Oncol. 2021 May;158:74-82. doi: 10.1016/j.radonc.2021.02.026. Epub 2021 Feb 25. Radiother Oncol. 2021. PMID: 33639190
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes.
Valeriani M, Bonfili P, Reverberi C, Marinelli L, Ferella L, Minniti G, DE Sanctis V, Osti MF, Bonome P, Tronnolone L, Varrassi E, Gravina GL, Franzese P, Tombolini V, DI Staso M. Valeriani M, et al. Among authors: ferella l. Anticancer Res. 2018 Mar;38(3):1671-1676. doi: 10.21873/anticanres.12400. Anticancer Res. 2018. PMID: 29491101
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
Marampon F, Leoni F, Mancini A, Pietrantoni I, Codenotti S, Ferella L, Megiorni F, Porro G, Galbiati E, Pozzi P, Mascagni P, Budillon A, Maggio R, Tombolini V, Fanzani A, Gravina GL, Festuccia C. Marampon F, et al. Among authors: ferella l. J Cancer Res Clin Oncol. 2019 Feb;145(2):393-409. doi: 10.1007/s00432-018-2800-8. Epub 2018 Nov 24. J Cancer Res Clin Oncol. 2019. PMID: 30474756
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis.
Ferella L, Limoncin E, Vittorini F, Chalaszczyk A, Sorce C, Grimaldi G, Franzese P, Ruggieri V, Varrassi E, Di Staso M, Gimenez De Lorenzo R, Marampon F, Tombolini V, Masciocchi C, Gravina GL. Ferella L, et al. Crit Rev Oncol Hematol. 2019 Jul;139:75-82. doi: 10.1016/j.critrevonc.2019.04.012. Epub 2019 Apr 27. Crit Rev Oncol Hematol. 2019. PMID: 31112885
18 results